Literature DB >> 12835101

Intraneuronal dopamine-quinone synthesis: a review.

D Sulzer1, L Zecca.   

Abstract

Dopamine-quinone is synthesized by oxidation of the catechol ring of dopamine. If this occurs within the neuronal cytosol, the quinone may react with cytosolic components, particularly with cysteine residues. In contrast, if quinone is produced within neuronal lysosomes it may provide the fundamental building block for neuromelanin. Since the population of neurons that die in Parkinson's disease are those that display obvious intralysosomal neuromelanin and since cytosolic dopamine-dependent oxyradical formation may underlie methamphetamine toxicity and other specific forms of neurodegeneration in dopaminergic neurons, it is important to elucidate the pathways leading to production of dopamine-quinone. Here we review pathways by which intracellular catechols may be oxidized to quinones, either enzymatically or via reduction of ferric iron or other metals. These metabolites can be adduced by cysteine, could underlie aberrant metabolism and ubiquitination pathways, may induce Lewy body formation, and mediate the synthesis of hydroxyl radical and oxyradical species. Finally, we suggest that by accumulating excess cytosolic catecholamine, neuromelanin synthesis may safely sequester quinones that would otherwise be produced in the neuronal cytosol.

Entities:  

Year:  2000        PMID: 12835101     DOI: 10.1007/bf03033289

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  122 in total

1.  Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture.

Authors:  M A Mena; U Khan; D M Togasaki; D Sulzer; C J Epstein; S Przedborski
Journal:  J Neurochem       Date:  1997-07       Impact factor: 5.372

2.  The chemical characterization of melanin contained in substantia nigra of human brain.

Authors:  L Zecca; C Mecacci; R Seraglia; E Parati
Journal:  Biochim Biophys Acta       Date:  1992-01-16

3.  Deposition of detergent-resistant neurofilaments into Lewy body fibrils.

Authors:  M S Pollanen; C Bergeron; L Weyer
Journal:  Brain Res       Date:  1993-02-12       Impact factor: 3.252

4.  Chaperoning brain diseases.

Authors:  W J Welch; P Gambetti
Journal:  Nature       Date:  1998-03-05       Impact factor: 49.962

Review 5.  Degradation of oxidized proteins in mammalian cells.

Authors:  T Grune; T Reinheckel; K J Davies
Journal:  FASEB J       Date:  1997-06       Impact factor: 5.191

6.  Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease.

Authors:  G Walkinshaw; C M Waters
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

Review 7.  Amphetamine: effects on catecholamine systems and behavior.

Authors:  L S Seiden; K E Sabol; G A Ricaurte
Journal:  Annu Rev Pharmacol Toxicol       Date:  1993       Impact factor: 13.820

8.  Cysteinyldopamine is not incorporated into neuromelanin.

Authors:  K Wakamatsu; S Ito; T Nagatsu
Journal:  Neurosci Lett       Date:  1991-09-30       Impact factor: 3.046

9.  Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine.

Authors:  M J LaVoie; T G Hastings
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

10.  Cu/Zn superoxide dismutase-like immunoreactivity is present in Lewy bodies from Parkinson disease: a light and electron microscopic immunocytochemical study.

Authors:  K Nishiyama; S Murayama; J Shimizu; Y Ohya; S Kwak; K Asayama; I Kanazawa
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

View more
  90 in total

1.  Oxidatively generated DNA damage after Cu(II) catalysis of dopamine and related catecholamine neurotransmitters and neurotoxins: Role of reactive oxygen species.

Authors:  Wendy A Spencer; Jeyaprakash Jeyabalan; Sunita Kichambre; Ramesh C Gupta
Journal:  Free Radic Biol Med       Date:  2010-11-12       Impact factor: 7.376

2.  Proceedings: cell therapies for Parkinson's disease from discovery to clinic.

Authors:  Rosa Canet-Aviles; Geoffrey P Lomax; Ellen G Feigal; Catherine Priest
Journal:  Stem Cells Transl Med       Date:  2014-08-22       Impact factor: 6.940

3.  Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus.

Authors:  Tonya N Taylor; Shawn P Alter; Minzheng Wang; David S Goldstein; Gary W Miller
Journal:  Neuropharmacology       Date:  2013-09-08       Impact factor: 5.250

Review 4.  L-DOPA treatment from the viewpoint of neuroprotection. Possible mechanism of specific and progressive dopaminergic neuronal death in Parkinson's disease.

Authors:  Norio Ogawa; Masato Asanuma; Ikuko Miyazaki; Francisco J Diaz-Corrales; Ko Miyoshi
Journal:  J Neurol       Date:  2005-10       Impact factor: 4.849

5.  Review of apoptosis vs. necrosis of substantia nigra pars compacta in Parkinson's disease.

Authors:  R M Kostrzewa
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

6.  Dopamine selectively sensitizes dopaminergic neurons to rotenone-induced apoptosis.

Authors:  Ferogh A Ahmadi; Tom N Grammatopoulos; Andy M Poczobutt; Susan M Jones; Laurence D Snell; Mita Das; W Michael Zawada
Journal:  Neurochem Res       Date:  2007-11-10       Impact factor: 3.996

7.  Saturation Binding of Nicotine to Synthetic Neuromelanin Demonstrated by Fluorescence Spectroscopy.

Authors:  Robert L Haining; Travis M Jones; Aubrey Hernandez
Journal:  Neurochem Res       Date:  2016-09-23       Impact factor: 3.996

Review 8.  Neuroinflammation in L-DOPA-induced dyskinesia: beyond the immune function.

Authors:  Augusta Pisanu; Laura Boi; Giovanna Mulas; Saturnino Spiga; Sandro Fenu; Anna R Carta
Journal:  J Neural Transm (Vienna)       Date:  2018-03-14       Impact factor: 3.575

Review 9.  Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease.

Authors:  Masato Asanuma; Ikuko Miyazaki; Norio Ogawa
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

10.  Effects of 1,4-butanediol administration on oxidative stress in rat brain: study of the neurotoxicity of gamma-hydroxybutyric acid in vivo.

Authors:  Angela M Sgaravatti; Alessandra S Magnusson; Amanda S Oliveira; Caroline P Mescka; Fernanda Zanin; Mirian B Sgarbi; Carolina D Pederzolli; Angela T S Wyse; Clóvis M D Wannmacher; Moacir Wajner; Carlos S Dutra-Filho
Journal:  Metab Brain Dis       Date:  2009-03-19       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.